Want to join the conversation?
Douglas Clark of Goldman Sachs asks about international revenue guidance. $ADTN said it expected international to be flattish but the company wanted to have some flexibility between regions. $ADTN is looking for a potential uptick in the European base which is material enough for the company to expect flattish results.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.